lysophosphatidic acid has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, JO; Jun, HS; Kim, D; Kim, HJ; Roh, JY | 1 |
| Jun, HS; Khin, PP; Kim, D; Lim, OK | 1 |
| Chen, C; Chen, X; Kuang, Y; Lei, L; Li, J; Liu, P; Peng, C; Yan, B; Zhu, W | 1 |
3 other study(ies) available for lysophosphatidic acid and Psoriasis
| Article | Year |
|---|---|
Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Topics: Animals; Apoptosis; Biomarkers; Cell Cycle; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Humans; Imiquimod; Interferon Inducers; Keratinocytes; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Receptors, Lysophosphatidic Acid; rho-Associated Kinases | 2021 |
LPA/LPAR1 signaling induces PGAM1 expression via AKT/mTOR/HIF-1α pathway and increases aerobic glycolysis, contributing to keratinocyte proliferation.
Topics: Animals; Cell Proliferation; Glycolysis; Keratinocytes; Mice; Proto-Oncogene Proteins c-akt; Psoriasis; TOR Serine-Threonine Kinases | 2022 |
Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5.
Topics: Humans; Keratinocytes; Lysophospholipids; Psoriasis; Receptors, Lysophosphatidic Acid | 2021 |